ABSTRACT
Boron containing compound (BCC) offers the potential further development for therapy against malignant cancers.We successfully synthesized a new compound based on curcumin structure (curcumin analogue) containing boronatoms, namely, CCB-2 and revealed its cytotoxic activities on various cancer cell lines. The compound was simplysynthesized based on aldol condensation using acetone and 4-formylphenyl boronic acid resulted a symmetry CCB-2.The compound was then tested for cytotoxic activities in several cell lines. CCB-2 demonstrated cytotoxic effect onMCF-7/HER-2, MCF-7, RAW 264.7, and 4T1 with IC50 value of 12 µM, 54 µM, 26 µM, and < 10 µM, respectively,while less toxic in fibroblast cells. This compound performed superior cytotoxic against highly metastatic cancer cell,4T1. In addition, CCB-2 induced cells accumulation in G2/M phase, but decreased the accumulation of intracellularReactive oxygen species level in 4T1 cells. All the data suggest that this new compound is promising to be developedas anti-cancer agent rather than for Boron Neutron Capture Therapy-based cancer therapy